MCMT
AGN

Moon Capital Management (Tennessee)’s Allergan plc AGN Stock Holding History

Moon Capital Management (Tennessee)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,285
Closed -$3.95M – 42
2020
Q1 		$3.95M Sell
22,285
-905
-4% -$170K 5.43% 5
2019
Q4 		$4.43M Buy
+23,190
New +$4.18M 4.61% 7

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Moon Capital Management (Tennessee)'s AGN Position: Q2 2020 in Review

Moon Capital Management (Tennessee) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 22,285 shares — an estimated $3.95M sold.

Moon Capital Management (Tennessee) first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $4.43M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Moon Capital Management (Tennessee) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Moon Capital Management (Tennessee) sold 22,285 Allergan plc shares in Q2 2020, an estimated $3.95M.
  • Moon Capital Management (Tennessee) first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Moon Capital Management (Tennessee)'s Allergan plc position peaked at $4.43M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Moon Capital Management (Tennessee)'s 13F filing for Q2 2020, filed 24 Aug 2020.